The Board of Syngenta confirmed today that it had recently received an unsolicited proposal from Monsanto to acquire the company at a price of CHF449 ($486.19) per Syngenta share with approximately 45% in cash.  Syngenta's Board of Directors, in conjunction with its legal and financial advisers, did a thorough review of all aspects of Monsanto's offer and unanimously decided to reject Monsanto's proposal, which it said was not in the best interests of Syngenta, its shareholders and its stakeholders

“The offer fundamentally undervalues Syngenta's prospects and underestimates the significant execution risks, including regulatory and public scrutiny at multiple levels in many countries,” the company said in a statement.

"Syngenta is the world leader in crop protection, the number three in seeds and the first company to introduce integrated solutions for growers,” said Michel Demare, Syngenta chairman. “Monsanto's proposal does not reflect the outstanding growth prospects of Syngenta's integrated strategy and the significant future value potential of the company's crop-focused innovation and market leading positions.”

Demare said that while Syngenta's valuation is currently being affected by short term currency and commodity price movements, the business outlook is strong, with emerging markets accounting for over 50% of our sales.

“Our integrated strategy has been particularly successful in these markets which in 2014 registered double digit growth rates for the fifth consecutive year, and which represent a major part of the future growth potential for our industry,” he said.

According to the company, recently launched new products have been achieving rapid sales growth globally. Demare said the Syngenta has a strong pipeline of innovative crop protection products in development, which have total peak sales potential of over $3 billion.

"In 2015, we are on track to achieve the first $265 million of savings from our Accelerating Operational Leverage Program, and we are targeting savings of $1 billion in 2018,” said Demare. “This will allow us to realize the full benefits of the integrated strategy and will ensure that increases in profitability are sustained for the benefit of Syngenta's shareholders."